(Q41095765)

26 September 2017

title

Improved discriminatory properties between human and murine tachykinin NK1 receptors of MEN 10930: a new potent and competitive antagonist (English)

1 reference

26 September 2017

0 references

Astolfi M

1

1 reference

26 September 2017

Patacchini R

series ordinal

2

1 reference

26 September 2017

Maggi M

series ordinal

3

1 reference

26 September 2017

Manzini S

series ordinal

4

1 reference

26 September 2017

publication date

1 August 1997

1 reference

26 September 2017

1 reference

26 September 2017

volume

31

1 reference

26 September 2017

issue

4

1 reference

26 September 2017

page(s)

373-379

1 reference

NK1-receptors mediate the proliferative response of human fibroblasts to tachykinins

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2897%2990074-3

7 January 2021

Diversity in mammalian tachykinin peptidergic neurons: multiple peptides, receptors, and regulatory mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2897%2990074-3

7 January 2021

Stress, symmetry, and psoriasis: possible role of neuropeptides.

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2897%2990074-3

7 January 2021

Receptors for sensory neuropeptides in human inflammatory diseases: implications for the effector role of sensory neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2897%2990074-3

7 January 2021

The tachykinin NK1 receptor antagonist CP-99,994 attenuates cisplatin induced emesis in the ferret

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2897%2990074-3

7 January 2021

Tachykinin receptors and tachykinin receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2897%2990074-3

7 January 2021

Broad spectrum antiemetic effects of CP-122,721, a tachykinin NK1 receptor antagonist, in ferrets

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2897%2990074-3

7 January 2021

A Potent Nonpeptide Antagonist of the Substance P (NK 1 ) Receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2897%2990074-3

7 January 2021

Investigation into species variants in tachykinin NK1 receptors by use of the non-peptide antagonist, CP-96,345

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2897%2990074-3

7 January 2021

Pharmacological profile of a high affinity dipeptide NK1 receptor antagonist, FK888

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2897%2990074-3

7 January 2021

The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2897%2990074-3

7 January 2021

Synthesis and substance P receptor binding activity of androstano[3,2-b]pyrimido[1,2-a]benzimidazoles

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2897%2990074-3

7 January 2021

In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2897%2990074-3

7 January 2021

Molecular cloning, structural characterization and functional expression of the human substance P receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2897%2990074-3

7 January 2021

Molecular cloning of substance P receptor cDNA from guinea-pig uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2897%2990074-3

7 January 2021

Human substance P receptor (NK-1): organization of the gene, chromosome localization, and functional expression of cDNA clones

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2897%2990074-3

7 January 2021

Comparison of tachykinin NK1 receptors in human IM9 and U373 MG cells, using antagonist (FK888, (+/-)-CP-96,345, and RP 67580) binding

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2897%2990074-3

7 January 2021

Characterization of receptors for substance P in human astrocytoma cells: radioligand binding and inositol phosphate formation

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2897%2990074-3

7 January 2021

Characterization and autoradiographic mapping of [3H]CP96,345, a nonpeptide selective NK1 receptor antagonist in guinea pig lung.

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2897%2990074-3

7 January 2021

[3H][beta-Ala8]neurokinin A-(4-10): a novel, selective radioligand for the tachykinin NK2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2897%2990074-3

7 January 2021

Characterization of NK-3 binding sites in rat and guinea pig cortical membranes by the selective ligand [3H]Senktide

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2897%2990074-3

7 January 2021

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2897%2990074-3

7 January 2021

Some quantitative uses of drug antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2897%2990074-3

7 January 2021

Non-specific actions of the non-peptide tachykinin receptor antagonists, CP-96,345, RP 67580 and SR 48968, on neurotransmission

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2897%2990074-3

7 January 2021

Non-specific inhibition of dopamine receptor agonist-induced behaviour by the tachykinin NK1 receptor antagonist CP-99,994 in guinea-pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0143-4179%2897%2990074-3

7 January 2021

10.1016/S0143-4179(97)90074-3

Identifiers

DOI

1 reference

26 September 2017

1 reference